Question 1

What is BPC-157?

Accepted Answer

BPC-157 (Body Protection Compound 157) is a synthetic 15-amino acid peptide derived from a protective protein found in human gastric juice. It has been studied extensively in preclinical rodent models across tissue repair, gastrointestinal cytoprotection, angiogenesis, and neuroprotection paradigms. The compound is not approved for human therapeutic use and is available for in vitro research purposes only.

Question 2

How does BPC-157 work in research models?

Accepted Answer

In preclinical research models, BPC-157 is primarily studied for its activity on the nitric oxide synthesis pathway, VEGF upregulation, and growth factor receptor interactions. Published studies document BPC-157 activating endothelial nitric oxide synthase, increasing VEGF expression at injury sites, and interacting with EGF and GH receptor signaling. These combined effects have been documented across tendon, gut, CNS, and vascular repair models. See the complete mechanism overview at /how-bpc-157-works/.

Question 3

What has BPC-157 been studied for in published preclinical research?

Accepted Answer

Published preclinical research has examined BPC-157 across tendon and ligament transection models (accelerated healing and collagen organization), gastrointestinal ulcer and fistula models (mucosal cytoprotection and repair), CNS ischemia and traumatic injury models (neuroprotection), vascular wound healing models (angiogenesis via VEGF), and systemic cytoprotection paradigms. The research body spans over three decades of rodent model work primarily from the Sikiric group.

Question 4

What is the half-life of BPC-157 in research models?

Accepted Answer

Published pharmacokinetic characterization of BPC-157 documents an approximate 4-hour half-life in preclinical rodent models. This value is from published pharmacokinetic studies in animal systems and is used in preclinical protocol timing design. Researchers designing BPC-157 animal studies should consult published pharmacokinetic data for model-specific parameters.

Question 5

How is BPC-157 stored for research use?

Accepted Answer

Research-grade BPC-157 should be stored in lyophilized powder form at -20 degrees Celsius for long-term stability, or at 2 to 8 degrees Celsius for short-term use. Once reconstituted in aqueous vehicle (typically sterile saline or bacteriostatic water for research use), reconstituted solutions should be used promptly or stored at 2 to 8 degrees Celsius and used within the timeframe specified by the manufacturer. These are standard peptide handling recommendations for in vitro research use.

Question 6

What purity standard should research-grade BPC-157 meet?

Accepted Answer

Research-grade BPC-157 is characterized by HPLC purity analysis and mass spectrometry confirmation. Standard research-grade specifications require at least 98% purity by HPLC with a Certificate of Analysis documenting the purity result, molecular weight confirmation, and batch number. Researchers sourcing BPC-157 for in vitro work should request COA documentation from the supplier.

Question 7

Is BPC-157 water soluble for research reconstitution?

Accepted Answer

BPC-157 is moderately water soluble and is typically reconstituted in sterile saline or bacteriostatic water for research applications. Published preclinical methodology sections commonly describe reconstitution in physiological saline for in vivo administration in animal models. For in vitro cell culture use, researchers typically reconstitute in water or DMSO-free aqueous vehicle to avoid solvent toxicity in cell systems.

Question 8

What key PubMed-indexed studies have been published on BPC-157?

Accepted Answer

The primary BPC-157 research literature is concentrated in publications from Sikiric and colleagues at the University of Zagreb, with dozens of peer-reviewed publications indexed in PubMed. Key studies include Achilles tendon transection models (Sikiric 2003, 2010), gastrointestinal cytoprotection studies (Sikiric 1994 through 2022), CNS and neuroprotection research (multiple Sikiric group publications), and angiogenesis models. Researchers can search PubMed for "BPC 157" to access the indexed literature.

Question 9

How does BPC-157 compare to TB-500 in tissue repair research?

Accepted Answer

BPC-157 and TB-500 have been studied through complementary mechanisms in published tissue repair research. BPC-157 acts primarily through local nitric oxide pathway activation and VEGF signaling at injury sites. TB-500 acts through actin sequestration (thymosin-beta-4 mechanism) with broader systemic tissue distribution. Published combination studies have documented additive effects in repair models. For a detailed comparison, see the BPC-157 vs TB-500 comparison page in the Research Library.

Question 10

Where can researchers source BPC-157 for in vitro research?

Accepted Answer

Research-grade BPC-157 for in vitro use is available from Spartan Peptides with at least 98% HPLC-verified purity, independent batch testing, and Certificate of Analysis documentation. All BPC-157 is for in vitro research use only and is not intended for human consumption. Domestic US supply with same-day dispatch is available for qualified research applications.

Question 11

What animal model types appear most commonly in published BPC-157 research?

Accepted Answer

The published BPC-157 literature has predominantly used Sprague-Dawley and Wistar rat models, with the Sikiric group publishing the majority of foundational studies in these rodent systems. Some studies have extended to murine (mouse) models, and limited non-human primate data exists in the published literature. The rodent paradigm dominates the published BPC-157 research base, covering tendon, gut, CNS, and vascular injury model types.

Question 12

What does the published research say about BPC-157 stability and peptide integrity?

Accepted Answer

Published stability data for BPC-157 documents acceptable stability in lyophilized form under appropriate storage conditions. Researchers have characterized the peptide sequence by mass spectrometry as a quality confirmation standard. Published methodology sections note that the peptide maintains biological activity in standard aqueous vehicle preparations used in rodent model protocols. Researchers should verify peptide integrity through COA mass spectrometry confirmation before use in research.

GLP-3(Reta) | Triple-Agonist Metabolic Research

NAD+ 750mg | Cellular Energy & DNA Repair Research

MOTS-c | Mitochondrial Metabolism Research Peptide

BPC-157 5mg | Tissue Repair & Gut Health Research

BPC-157 Frequently Asked Questions

Explore Full Research Index